Dexamethasone Impurity 33 - Request Quote
Dexamethasone Impurity 33
| SZ CAT No: | SZ-D024083 |
| CAS No | NA |
| Mol.F. | C21H26ClFO5 |
| Mol.Wt. | 412.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dexamethasone Impurity 33 is chemically (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6-Chloro-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid. Dexamethasone Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Dexamethasone Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dexamethasone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Dexamethasone Impurity 33
Purchase Dexamethasone Impurity 33
Dexamethasone Impurity 33 suppliers
Dexamethasone Impurity 33 manufacturers
Dexamethasone Impurity 33 price
Order Dexamethasone Impurity 33
Enquire Dexamethasone Impurity 33
Dexamethasone Impurity 33 cost
Dexamethasone Impurity 33 Supplier
Dexamethasone Impurity 33 Distributor
Dexamethasone Impurity 33 for Method Validation
Dexamethasone Reference Standard
Dexamethasone Impurity 33 for ANDA Filing
Dexamethasone Impurity 33 for Forced Degradation Studies
Dexamethasone Impurity 33 Identification Standards
Dexamethasone Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.